Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.046
Sell
RSI(14)
33.803
Neutral
STOCH(KDJ)(9,3,3)
13.253
Oversold
ATR(14)
1.198
Low Volatility
CCI(14)
-94.123
Neutral
Williams %R
88.198
Oversold
TRIX(12,20)
-0.606
Sell
StochRSI(14)
53.771
Buy
SNWV
SNWV25.830USD
+0.270+1.06%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
221.52MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of SNWV
Currency: USD Updated: 2026-02-06Key Insights
SANUWAVE Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 88 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 54.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
SNWV's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
SNWV Highlights
StrengthsRisks
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 94.92% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.63M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 32.63M.
Undervalued
The company’s latest PE is -49.97, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.37M shares, decreasing 11.47% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 445.21K shares of this stock.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
54.000
Target Price
+109.55%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-06The current financial score of SANUWAVE Health Inc is 7.05, ranking 106 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 11.45M, representing a year-over-year increase of 22.34%, while its net profit experienced a year-over-year increase of 149.98%.
Score
Financials
5.98
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.60
Operational Efficiency
8.51
Growth Potential
7.02
Shareholder Returns
7.14
SNWV's Company Valuation
Currency: USD Updated: 2026-02-06The current valuation score of SANUWAVE Health Inc is 6.73, ranking 154 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -49.97, which is -93.72% below the recent high of -3.14 and -37.79% above the recent low of -68.85.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 88/205
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-06The current earnings forecast score of SANUWAVE Health Inc is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 54.00, with a high of 55.00 and a low of 53.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
54.000
Target Price
+109.55%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
114
Total
6
Median
9
Average
Company name
Ratings
Analysts
SNWV
2
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Medtronic PLC
MDT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-06The current price momentum score of SANUWAVE Health Inc is 6.33, ranking 156 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 30.64 and the support level at 23.24, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
25.990
Sell
MA10
26.389
Sell
MA20
27.236
Sell
MA50
29.787
Sell
MA100
31.332
Sell
MA200
32.659
Sell
Institutional Confidence
Currency: USD Updated: 2026-02-06Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Opaleye Management Inc.
Manchester Management Company, L.L.C.
AWM Investment Company, Inc.
BlackRock Institutional Trust Company, N.A.
Solas Capital Management, LLC
Geode Capital Management, L.L.C.
State Street Investment Management (US)
CenterBook Partners LP
Northern Trust Investments, Inc.
1
2
Risk Assessment
Currency: USD Updated: 2026-02-06The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of SANUWAVE Health Inc is 4.11, ranking 111 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.31. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.31
VaR
+13.93%
240-Day Maximum Drawdown
--
240-Day Volatility
--
Return
Best Daily Return
60 days
+10.23%
120 days
+17.68%
5 years
+5614.29%
Worst Daily Return
60 days
-8.61%
120 days
-21.58%
5 years
-98.25%
Sharpe Ratio
60 days
-1.48
120 days
-0.82
5 years
+0.52
Risk Assessment
Maximum Drawdown
240 days
--
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
--
3 years
--
5 years
--
Skewness
240 days
+0.18
3 years
+0.87
5 years
+34.16
Volatility
Realised Volatility
240 days
--
5 years
--
Standardised True Range
240 days
--
5 years
--
Downside Risk-Adjusted Return
120 days
-118.04%
240 days
-118.04%
Maximum Daily Upside Volatility
60 days
+35.19%
Maximum Daily Downside Volatility
60 days
+31.39%
Liquidity
Average Turnover Rate
60 days
+0.97%
120 days
+0.79%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--
Peer Comparison
Healthcare Equipment & Supplies
SNWV
6.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
